Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections.

ABSTRACT: The emerging human coronavirus infections in the 21st century remain a major public health crisis causing worldwide impact and challenging the global health care system. The virus is circulating in several zoonotic hosts and continuously evolving, causing occasional outbreaks due to spill-over events occurring between animals and humans. Hence, the development of effective vaccines or therapeutic interventions is the current global priority in order to reduce disease severity, frequent outbreaks, and to prevent future infections. Vaccine development for newly emerging pathogens takes a long time, which hinders rapid immunization programs. The concept of plant-based pharmaceuticals can be readily applied to meet the recombinant protein demand by means of transient expression. Plants are evo

SUBMITTER: Shanmugaraj B 

PROVIDER: S-EPMC8400130 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature